Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Advanced stage laryngeal squamous cell carcinoma (LSCC) presents a poor prognosis; thus, there is a great need to identify novel prognostic molecular markers. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) is thought to be a novel prognostic factor in several cancers, but its role in LSCC remains unknown. | PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics
